NASDAQ Comp.
14.05.2007 23:01:00
|
HealthTronics Announces FDA Clearance and Launch of the New LithoDiamond ULTRA Lithotripter
HealthTronics, Inc. (NASDAQ: HTRN), a leading provider of urology
services and products, announces the launch of its LithoDiamond ULTRA
lithotripter providing an evolution in lithotripsy treatment technology.
FDA clearance of the equipment has been granted and over fifty patients
have been treated. This platform evolution is the largest advancement in
lithotripsy technology in more than a decade and is based on the
significant input from our urologist partners and clinicians in the
urology community. The LithoDiamond ULTRA has five unique clinical
features that define it as the most technologically and clinically
advanced lithotripter available in the global marketplace today. These
features include:
"Source Select”
technology which provides both electrohydraulic, or "spark
gap” therapy delivery, as well as
electromagnetic therapy delivery (the capability of two units in one,
providing enhanced treatment options)
Rotating therapy head that provides unencumbered access to both sides
of the patient for treating kidney and lower ureteral stones in either
the supine or prone position
Integrated iso-centric C-arm and image chain which
provides optimal image quality to visualize stones in the kidney and
ureter
Mobile platform consisting of only two components for excellent
portability and productivity
Table functionality that allows for cysto, prostate and other surgical
procedures
The first patient treatments were conducted by David Allen, MD of
Athens, GA who stated: "We treated four cases
on the ULTRA, two with the electromagnetic therapy head and two with the
electrohydraulic therapy head. Changing therapy heads between cases was
a simple procedure and having the ability to choose the electrohydraulic
head with a deeper penetration depth is a great option for larger
patients which is one of the fastest growing market segments in medicine
today. The image quality on the ULTRA provides for excellent stone
localization. This lithotripter is a versatile product with a bright
future.”
Christopher Schneider, President of Medical Products commented: "HealthTronics
has always been a strong player in electrohydraulic lithotripsy
technology but has never invested in the other 50% of the lithotripsy
market which consists of electromagnetic technology. The LithoDiamond
ULTRA is the first unit ever produced to combine both
technologies on one unit. Now, a provider can satisfy the clinical
requirements of all urologists by purchasing one unit that offers both
types of therapy rather than purchasing two single technology units.
This combination of technology can potentially reduce a provider’s
lithotripsy capital costs in half. We are excited about the next
generation brand of LithoDiamond which demonstrates a continuum of
technology, preceded by our 190 lithotripters installed in the United
States and our additional 140 lithotripters installed internationally.” HealthTronics is a premier urology company providing an exclusive
suite of healthcare services and technology including urologist
partnership opportunities, surgical and capital imaging equipment,
maintenance services offerings, and clinical and anatomical pathology
services.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.